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Not Your Typical Case Of Ascites: Pancreatic Ascites In 
A Patient With Cirrhosis And Pancreatic Duct Leak
Philip Montemuro, MD and Abhik Roy, MD
Case
A 55-year-old male with a history of hepatic cirrhosis secondary 
to Hepatitis C and alcohol abuse presented to an outside 
hospital with progressive abdominal pain and distension. The 
patient initially complained of “punching” right upper quadrant 
and epigastric abdominal pain that was 10/10 in intensity and 
non-radiating. Although the pain had started one to two days 
prior to presentation, the patient had been experiencing several 
weeks of increasing abdominal distension. He reported drinking 
eight 40oz beers daily for over 40 years, and he felt that the 
abdominal pain improved slightly with cessation of alcohol use. 
The patient complained of nausea and non-bloody, non-bilious 
vomiting, progressive dyspnea on exertion, and worsening 
lower extremity edema. He denied fevers or chills. 
Limited outside hospital records indicated that the patient had 
been stable on diuretics for one month prior to admission. He 
required three large volume paracenteses during his six days at 
the outside facility, and he was transferred to Thomas Jefferson 
University Hospital for further management of his refractory 
ascites. Medications on transfer included lactulose, furosemide, 
spironolactone, and octreotide. The patient was also receiving 
total parenteral nutrition (TPN) via a Peripherally Inserted 
Central Catheter (PICC). 
At the time of transfer, the patient was afebrile with stable vital 
signs. On physical exam, he appeared cachectic with temporal 
wasting. The abdominal exam revealed a soft abdomen with 
moderate distension, diffuse tenderness to palpation without 
rebound or guarding, positive fluid wave and shifting dullness, 
and no organomegaly or collateral circulation. Spider angiomata 
were present on the chest. Lower extremity edema, palmar 
erythema, jaundice, and gynecomastia were not appreciable. 
Complete blood count on transfer showed white count 10,900/L, 
hemoglobin 9.1 g/dL, and platelets 110/L. The chemistry 7 was 
remarkable for sodium 133 mmol/L and creatinine 0.7 mg/dL. 
INR was 1.4, and liver function tests showed total protein 5.0 g/
dL, albumin 1.9 g/dL, total bilirubin 0.7 mg/dL, direct bilirubin 
0.3 mg/dL, AST and ALT of 17 IU/L, and alkaline phosphatase 
38 IU/L. Serum lipase and amylase were 645 U/L and 330 
U/L respectively. Hepatitis C antibody was positive with a 
quantitative polymerase chain reaction (PCR) of 5130 IU/mL. 
On the day of transfer, a bedside paracentesis had been performed 
at the outside hospital and showed clear yellow fluid with 94 red 
blood cells, 69 white blood cells (15% PMN, 50% lymphocytes, 
and 35% monocytes), and a negative gram stain and culture. 
Ascites albumin was 0.7 g/dL, yielding a serum-ascites albumin 
gradient (SAAG) of 1.2. Of note, the ascites total protein was 
2.1 and ascites amylase was significantly elevated at 4000. An 
Figure 1. Pancreatic duct leak with contrast extravasation into 
the retroperitoneum (white arrow)
Figure 2. Two stents were placed to fix the pancreatic duct 
leak and impaired biliary drainage (the white arrow shows 
the pancreatic duct stent; the red arrow shows the biliary 
duct stent)
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abdominal magnetic resonance imaging (MRI)/magnetic 
resonance cholangiopancreatography (MRCP) had also been 
performed prior to transfer, and this study demonstrated 
a cirrhotic appearing liver, moderate to severe ascites with 
loculated appearance, and mild stenosis of the common hepatic 
duct with no intra- or extra-hepatic biliary ductal dilation or 
stones and no evidence of pancreatic pseudocyst. 
Given the rapid re-accumulation of ascites requiring multiple 
paracenteses at the outside hospital, the differential diagnosis 
at the time of transfer to Jefferson included progression of 
cirrhosis due to alcohol abuse or Hepatitis C, pancreatic ascites, 
hepatocellular carcinoma or metastatic liver disease, peritoneal 
carcinomatosis, Budd-Chiari syndrome, and auto-immune 
pancreatitis. Shortly after transfer, an abdominal Doppler 
ultrasound ruled out Budd-Chiari syndrome and detailed 
serum and ascitic fluid analysis (including cytology) led to the 
conclusion that most malignant and auto-immune etiologies 
were less likely. Given the SAAG ≥1.1 and high ascites amylase 
level, progressive cirrhosis (secondary to alcohol abuse and 
Hepatitis C) as well as a pancreatic etiology for ascites were 
believed to play a key role. 
An endoscopic retrograde cholangiopancreatography (ERCP) 
was performed to evaluate the pancreas and pancreatic duct 
architecture. ERCP revealed a large area of disruption of the major 
pancreatic duct (MPD) in the mid-body of the pancreas with 
extravasation of contrast into the retroperitoneum (Figure 1), 
white arrow illustrates contrast extravasation). This finding could 
certainly have explained the high amylase content in the ascitic 
fluid. In order to repair the pancreatic duct leak, a 5 French 12 cm 
Geenen stent was placed in the MPD across the area of mid-body 
pancreatic duct disruption (Figure 2, white arrow). Of note, a 
10 French 5 cm plastic stent was also placed in the biliary duct 
because there appeared to be impaired drainage of contrast from 
the biliary tree (Figure 2, red arrow).
Following the ERCP, the patient unfortunately developed 
chemical peritonitis (secondary to contrast injection during 
the ERCP procedure), which required prolonged antibiotic 
therapy. The patient was placed on a low sodium diet as well as 
a stable oral diuretic regimen. The combination of endoscopic, 
pharmacologic, and dietary interventions ultimately decreased 
the rate of re-accumulation of ascites. A repeat paracentesis 
performed prior to discharge showed a dramatic decrease in the 
ascites amylase level, demonstrating resolution of the pancreatic 
duct leakage which had contributed to the patient’s ascites. 
Discussion
In a patient with ascites of unclear etiology, several key points 
must be remembered. The most common causes of ascites are 
cirrhosis (81%), malignancy (10%), and heart failure (3%).4 The 
work-up should include history and physical exam, ultrasound, 
and paracentesis.5 
On physical exam, the most useful findings to suggest ascites 
include positive fluid wave and shifting dullness, while the 
absence of bulging flanks, flank dullness, or shifting dullness are 
the strongest findings arguing against ascites.3 Paracentesis and 
ascitic fluid analysis are essential for establishing a diagnosis 
and to rule out an infection. Routine ascitic fluid studies should 
include gross appearance of the fluid, total protein, albumin, cell 
count and differential, as well as gram stain and culture.1,4 Other 
tests to consider include fluid amylase, cytology, and many other 
less common studies that can be used when clinically indicated.1 
Calculating the serum-ascites albumin gradient (SAAG score) is 
key for establishing a diagnosis (see Table 1).1,4,5
Pancreatic ascites causes approximately 1% of all cases 
of ascites.4 The etiology is due to disruption of the main 
pancreatic duct causing pancreatic fluid accumulation in the 
peritoneal cavity.2 It is most commonly associated with chronic 
pancreatitis secondary to alcoholism, although 67% of patients 
have no recent pancreatitis flare.6,7 It can also be caused by 
an internal fistula between the pancreatic duct and peritoneal 
cavity, a leaking pseudocyst, or a ruptured duct.2 Pancreatic 
ascites is seen in 4% of chronic pancreatitis cases and 6-14% of 
pseudocyst cases.8,9 Clinically, it can present in patients with a 
history of chronic pancreatitis, recent acute pancreatitis, or new 
onset ascites. 
The diagnosis of pancreatic ascites is made by an elevated serum 
amylase along with ascitic fluid amylase > 1000 IU/L, SAAG 
<1.1, and total protein >3.1,2 In our patient, the SAAG and total 
protein were not consistent with a purely pancreatic cause given 
the known cirrhosis that was also contributing to his ascites. 
Imaging that can be utilized for diagnostic purposes include 
computed tomography (CT) scan to evaluate for a pseudocyst 
or evidence of pancreatitis as well as MRCP or ERCP. MRCP is 
utilized if the patient is not an ERCP candidate to examine the 
Table 1
SAAG ≥ 1.1,  
Ascites protein < 2.5 g/dL
SAAG ≥ 1.1,  
Ascites protein ≥ 2.5 g/dL
SAAG < 1.1
Cirrhosis Congestive heart failure 
Constrictive pericarditis
Biliary leak 
Nephrotic syndrome
Late Budd-Chiari syndrome Early Budd-Chiari syndrome 
IVC obstruction
Pancreatitis 
Peritoneal carcinomatosis
Massive liver metastasis Sinusoidal obstruction syndrome Tuberculosis
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main pancreatic duct. ERCP is favored as it is both diagnostic 
and therapeutic.2,10 As was the case for our patient, ERCP can 
show passage of contrast from either the MPD or pseudocyst 
into the peritoneal cavity. If this finding is present, a stent can be 
placed to occlude the site of disruption. Treatment includes both 
temporary and permanent options.2 The temporary measures 
are targeted at reducing pancreatic activity. This involves 
avoiding enteral feedings and utilizing naso-gastric suctioning 
and TPN when indicated. Octreotide is also effective in reducing 
pancreatic secretions. Permanent measures include ERCP with 
stent placement or surgical interventions if this fails.2
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